News for 'Safety Research'

Covaxin 50% effective against symptomatic Covid: Lancet

Covaxin 50% effective against symptomatic Covid: Lancet

Rediff.com24 Nov 2021

Results of an interim study recently published in The Lancet showed that two doses of Covaxin, also known as BBV152, had 77.8 per cent efficacy against symptomatic disease and present no serious safety concerns.

'GM Mustard Must Be Uprooted And Burnt'

'GM Mustard Must Be Uprooted And Burnt'

Rediff.com9 Dec 2022

'Why should our government opt for unproven technology that has been rejected by most countries across the globe?' 'Being dependent on any other nation to supply you seed for your good crops is another form of slavery.'

Anti-cancer drugs, antibiotics, vaccines set to become cheaper

Anti-cancer drugs, antibiotics, vaccines set to become cheaper

Rediff.com13 Sep 2022

Anti-infectives like Ivermectin, Mupirocin and Meropenem have also been added to the list, taking the total drugs under it to 384.

7 Jobs In The Metaverse

7 Jobs In The Metaverse

Rediff.com20 Apr 2022

By 2026, around 25 per cent of the global population may spend at least an hour a day on Metaverse. This will open the doors for many businesses, the NFTs market will spread, and Web 3.0 will attract more investment.

Rly seeks US help to ensure safety

Rly seeks US help to ensure safety

Rediff.com7 Aug 2007

Indian Railways is taking the help of a US-based railroad research organisation to study the impact of higher freight traffic load on tracks.

Covaxin shows 78% efficacy in phase-3 interim analysis

Covaxin shows 78% efficacy in phase-3 interim analysis

Rediff.com21 Apr 2021

Safety and Efficacy results from the final analysis will be available in June, and the final report will be submitted to a peer-reviewed publication.

Cong says Facebook influenced polls in India, seeks JPC probe

Cong says Facebook influenced polls in India, seeks JPC probe

Rediff.com25 Oct 2021

The Congress also alleged that Facebook was acting as an ally of the ruling BJP and pushing its agenda.

DRDO develops advanced chaff tech for IAF to fool enemy missiles

DRDO develops advanced chaff tech for IAF to fool enemy missiles

Rediff.com19 Aug 2021

The Defence Research and Development Organisation has developed an advanced chaff technology, which is used to distract enemy's radar-guided missiles, to safeguard Indian Air Force fighter jets from enemy missiles.

'The violence will stop decisively very soon'

'The violence will stop decisively very soon'

Rediff.com26 Jun 2023

'If the Kukis and Meiteis are the warring groups, then we need to find space for a third group which can mediate between the two.'

The A-W Of Desi Guests At the White House Dinner

The A-W Of Desi Guests At the White House Dinner

Rediff.com24 Jun 2023

The dinner Jill Biden and her husband US President Joe Biden hosted for Indian prime minister Narendra Modi, June 22, at the White House brought together, Indians and Americans from so many firmaments.

Covaxin gets nod for phase 2, 3 clinical trials on 2-18 year-olds

Covaxin gets nod for phase 2, 3 clinical trials on 2-18 year-olds

Rediff.com12 May 2021

The trial will take place in 525 subjects at various sites, including AIIMS, Delhi, AIIMS, Patna and Meditrina Institute of Medical Sciences, Nagpur.

Tata Motors launches Nexon EV MAX at Rs 17.74 lakh

Tata Motors launches Nexon EV MAX at Rs 17.74 lakh

Rediff.com11 May 2022

Tata Motors on Wednesday expanded its electric vehicle range in the country with the launch of Nexon EV MAX, priced between Rs 17.74-19.24 lakh (ex-showroom). Equipped with a 40.5 kWh lithium-ion battery pack, the Nexon EV Max offers 33 per cent higher battery capacity than the Nexon EV, delivering ARAI certified range of 437 km (under standard testing conditions), ensuring uninterrupted inter-city travel. ARAI refers to Automotive Research Association of India. The model produces 105 kW (143 PS) of power and delivers a torque of 250 Nm, resulting in 0 to 100 sprint times in under 9 seconds.

Oxford launches COVID-19 vaccine study on children

Oxford launches COVID-19 vaccine study on children

Rediff.com13 Feb 2021

This new trial, a single-blind, randomised Phase II trial, will enrol 300 volunteers, with up to 240 of these volunteers receiving the ChAdOx1 nCoV-19 vaccine and the remainder a control meningitis vaccine, which has been shown to be safe in children but is expected to produce similar reactions, such as a sore arm.

Google toughens privacy compliance, disclosures for app developers

Google toughens privacy compliance, disclosures for app developers

Rediff.com27 Apr 2022

Tech giant Alphabet on Monday launched a privacy feature on its app marketplace Google Play Store that will require developers to give people more information about how apps collect, share and secure users' data. Users will start seeing the data safety section in Google Play on Tuesday, and developers are required to complete this section for their apps by July 20. As app developers update their functionality or change their data handling practices, they will show the latest in the apps' data safety section.

FPIs withdrew Rs 41,000 cr in March

FPIs withdrew Rs 41,000 cr in March

Rediff.com3 Apr 2022

Continuing their selling spree for the sixth consecutive month, foreign investors pulled out a massive Rs 41,000 crore from the Indian equity market in March on anticipation of rate hikes by the US Federal Reserve and deteriorating geopolitical environment amid the Russia-Ukraine war. Further, flows from foreign portfolio investors (FPIs) are expected to remain volatile in the near term given the headwinds in terms of elevated crude prices and inflation, experts said. According to data available with the depositories, FPIs were net sellers to the tune of Rs 41,123 crore in the equity market last month.

India successfully test-fires two medium range missiles off Odisha coast

India successfully test-fires two medium range missiles off Odisha coast

Rediff.com27 Mar 2022

This MRSAM version is a surface-to-air missile developed jointly by DRDO and Israel Aerospace Industries for use by the Indian Army.

Modi raises temple attacks, pro-Khalistan activities with Australian PM

Modi raises temple attacks, pro-Khalistan activities with Australian PM

Rediff.com10 Mar 2023

The matter came up for discussion during their wide-ranging dialogue that was aimed at expanding overall ties.

Plinth work begins for Ram temple in Ayodhya

Plinth work begins for Ram temple in Ayodhya

Rediff.com27 Jan 2022

The third phase of the construction of the Ram temple began at Ramjanmabhoomi in Ayodhya on January 24 with the laying of the granite stones for the plinth.

Serum gets nod for phase 2, 3 trials of Covid vaccine in India

Serum gets nod for phase 2, 3 trials of Covid vaccine in India

Rediff.com3 Aug 2020

Currently, phase 2 and 3 clinical trials of the Oxford vaccine candidate is going on in the United Kingdom, phase 3 clinical trial in Brazil and phase 1 and 2 clinical trials in South Africa.

Boom Motors recalls Corbett ebikes, halts production after fatal accident

Boom Motors recalls Corbett ebikes, halts production after fatal accident

Rediff.com30 Apr 2022

So far at least eight incidents of EV fires have been reported in just over a month's time.

'Fear continues across Joshimath'

'Fear continues across Joshimath'

Rediff.com6 Feb 2023

'Cracks continue to appear in more and more houses.' 'We believe the government is not going to tell us the truth.'

Maha govt draws ire for sunstroke deaths as toll rises

Maha govt draws ire for sunstroke deaths as toll rises

Rediff.com17 Apr 2023

Labour union leader Shrirang Barge said the state government would have known Dharmadhikari has a massive following and that the event would have attracted several lakh people, so why were arrangements for water, shade etc, missing.

Uber needs to ensure passengers safety, says Yahoo chief

Uber needs to ensure passengers safety, says Yahoo chief

Rediff.com11 Dec 2014

Uber is present in over 250 cities in 50 countries.

Centre gives big push for use of drones in agriculture

Centre gives big push for use of drones in agriculture

Rediff.com22 Jan 2022

The Centre has, perhaps for the first time, decided to provide funding support to farmer-producer organisations, krishi vigyan kendras, custom hiring centres, and individuals for purchasing them.

'No preparedness planning, no accountability, no action plan'

'No preparedness planning, no accountability, no action plan'

Rediff.com8 May 2021

'This government did not have any plan for safety stocks of essential medicines.'

Bharat Biotech's Covaxin shipped to 11 cities in India

Bharat Biotech's Covaxin shipped to 11 cities in India

Rediff.com13 Jan 2021

After having received the government purchase order for 55 lakh doses, Bharat Biotech shipped the first batch of vaccines (each vial containing 20 doses) to Gannavaram (Vijayawada), Guwahati, Patna, Delhi, Kurukshetra, Bangalore, Pune, Bhubaneswar, Jaipur, Chennai and Lucknow.

Maruti to set up research and development centre at Rohtak

Maruti to set up research and development centre at Rohtak

Rediff.com26 Aug 2013

The testing facility at Rohtak would have more than 30 different tracks covering a length of about 30 km to check the various operational aspects of a vehicle.

'We've reduced hate speech by half'

'We've reduced hate speech by half'

Rediff.com26 Nov 2021

'Our proactive detection rate for hate speech in India is close to 97 per cent -- which means that of the hate speech content we remove, we detect 97 per cent of it proactively, even before anyone reports it.'

LIC's Adani Investment: 'Policyholders' Money Is Absolutely Safe'

LIC's Adani Investment: 'Policyholders' Money Is Absolutely Safe'

Rediff.com3 Feb 2023

'It's a clear case of political patronage helping an individual grow.'

Smaller cars ceding ground to bigger, pricey models

Smaller cars ceding ground to bigger, pricey models

Rediff.com21 Mar 2022

Size matters on the road. Small is not dominating India's car market any more. The share of cars priced up to Rs 5 lakh in the passenger vehicle market has fallen to 10.5 per cent in the first 11 months of 2021-22, compared with 26 per cent in 2018-19 (FY19), the lowest in four years, according to data from industry sources. Even the share of those in the price range between Rs 5 lakh and Rs 7.5 lakh has dropped to 32.4 per cent in the same period, from 34.9 per cent.

Expert panel seeks more data on SII, Bharat Biotech vaccines

Expert panel seeks more data on SII, Bharat Biotech vaccines

Rediff.com10 Dec 2020

An expert committee of the Central Drugs Standard Control Organisation (CDSCO) on Wednesday sought additional safety and efficacy data for COVID-19 vaccine candidates of Serum Institute and Bharat Biotech, after deliberating upon their applications seeking emergency use authorisation for the shots, official sources said.

Mixing Covishield, Covaxin shows better immunogenicity: ICMR study

Mixing Covishield, Covaxin shows better immunogenicity: ICMR study

Rediff.com8 Aug 2021

The study titled 'Serendipitous COVID-19 Vaccine-Mix in Uttar Pradesh, India: Safety and Immunogenicity Assessment of a Heterologous Regime' has been uploaded on medRxiv, a preprint server and is yet to be peer reviewed.

COVID vaccine likely to be available by first of 2021: Choubey

COVID vaccine likely to be available by first of 2021: Choubey

Rediff.com19 Sep 2020

Responding to another question, Choubey said that the phase-I of clinical trials have revealed excellent safety of the two candidate vaccines indigenously developed by Bharat Biotech in collaboration with Indian Council of Medical Research and Cadila Healthcare Ltd, and now their immunogenicity testing is in progress. Their phase II clinical trials are ongoing.

Vaxed pregnant women pass antibodies to babies: Study

Vaxed pregnant women pass antibodies to babies: Study

Rediff.com23 Sep 2021

Women who receive the mRNA COVID-19 vaccine during pregnancy pass high levels of antibodies to their babies, according to a study.

Why do world's best footballers struggle with penalties?

Why do world's best footballers struggle with penalties?

Rediff.com10 Dec 2022

The most notable aspect of both 2022 shootouts was the shockingly poor quality of the kicks.

FIA probes Grosjean's crash

FIA probes Grosjean's crash

Rediff.com3 Dec 2020

The FIA expected its investigation to take six to eight weeks. It will look at all safety devices, how the safety barrier performed and the role of track marshals and medical intervention team.

Airports Authority may procure two counter-drone systems

Airports Authority may procure two counter-drone systems

Rediff.com14 Nov 2021

The The Airports Authority of India is likely to procure two counter-drone systems worth Rs 9.9 crore in 2022-23, according to an official document.

IMA requests its 3.5 lakh members to voluntarily get vaccinated

IMA requests its 3.5 lakh members to voluntarily get vaccinated

Rediff.com11 Jan 2021

"The Indian Medical Association has requested all its 3.5 lakh members in 1,800 local branches to voluntarily come out to get vaccinated first to show the world that these vaccines are safe and efficacious," it said.

Mega clean-up drive in full swing post Noida twin tower demolition

Mega clean-up drive in full swing post Noida twin tower demolition

Rediff.com30 Aug 2022

While Emerald Court would take one more day to be cleaned, the work at ATS Village could extend up to seven days due to more rubble and dust on the premises, according to officials.

US says Covaxin successfully neutralises Delta variant

US says Covaxin successfully neutralises Delta variant

Rediff.com30 Jun 2021

The NIH said results of two studies of blood serum from people who had received Covaxin suggest that the vaccine generates antibodies that effectively neutralise the B.1.1.7 (Alpha) and B.1.617 (Delta) variants of SARS-CoV-2, first identified in the United Kingdom and India, respectively.